Most Recent
Court hands win to Boehringer in fight over Zoetis vaccine patents
German drug maker Boehringer has prevailed in its Federal Court fight against US rival Zoetis over the validity of three patents covering pig vaccines.
Qld tech firm denies using confidential info for battery patent applications
Queensland technology company Anteotech has hit back at a lawsuit claiming it misused Ferroglobe’s confidential silicon samples in a patent application after a failed collaboration, saying the global speciality metals producer acquiesced to the use. 
Cipla sues to invalidate Bristol-Myers’ patents for DVT drug
Indian generic drug maker Cipla has sued pharmaceutical giants Bristol-Myers Squibb and Pfizer alleging the patents behind their blockbuster deep vein thrombosis drug Eliquis are invalid.
High Court won’t step in to revive Energy Beverages’ ‘Motherland’ trade mark
The maker of Mother Energy drinks has failed to convince the High Court that it should weigh in on its long-running intellectual property spat with Vittoria Coffee, which ended in the removal of its 'Motherland' trade mark.
Zip offered Firstmac $4M to settle trade mark suit
Buy now, pay later company Zip Co offered $4 million to settle a lawsuit by mortgage provider Firstmac alleging infringement of its 'Zip' trade mark which it ultimately defeated.
NAB sues You Need A Budget app, says brand will confuse Aussies
National Australia Bank is suing US company You Need A Budget, alleging the YNAB app, which helps users manage their finances, steps on its well-known trade mark and will confuse Australians.
Directed Electronics loses appeal in Hanhwa trade secrets case
Automotive electronics company Directed Electronics has lost its bid to revive copyright claims against a form business partner who it pursued as part of litigation over a scheme by two former employees to misappropriate its trade secrets through a secret side agreement with South Korean giant Hanhwa.
Lights out on Hanhwa’s solar cell patent infringement suit
A solar cell patent at the heart of intellectual property litigation brought by South Korean technology giant Hanwha has been found invalid.
Government brings $325M High Court challenge over generic Plavix ban
A 16-year battle between the federal government and drug maker Sanofi-Aventis over an allegedly unjustified court order that prevented the release of a generic version of blockbuster blood-thinner Plavix has gone to the High Court.